AC Immune SA (ACIU)
3.00
+0.16
(+5.63%)
USD |
NASDAQ |
Nov 01, 16:00
2.99
-0.01
(-0.33%)
After-Hours: 20:00
AC Immune Total Assets (Quarterly): 264.24M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 264.24M |
| March 31, 2024 | 185.40M |
| December 31, 2023 | 217.65M |
| September 30, 2023 | 156.28M |
| June 30, 2023 | 173.73M |
| March 31, 2023 | 185.17M |
| December 31, 2022 | 200.55M |
| September 30, 2022 | 210.79M |
| June 30, 2022 | 227.16M |
| March 31, 2022 | 255.10M |
| December 31, 2021 | 286.01M |
| September 30, 2021 | 217.66M |
| June 30, 2021 | 229.20M |
| March 31, 2021 | 242.00M |
| December 31, 2020 | 273.26M |
| September 30, 2020 | 279.05M |
| June 30, 2020 | 287.31M |
| March 31, 2020 | 300.22M |
| Date | Value |
|---|---|
| December 31, 2019 | 308.85M |
| September 30, 2019 | 318.12M |
| June 30, 2019 | 303.24M |
| March 31, 2019 | 314.24M |
| December 31, 2018 | 199.64M |
| September 30, 2018 | 212.69M |
| June 30, 2018 | 112.81M |
| March 31, 2018 | 125.86M |
| December 31, 2017 | 135.52M |
| September 30, 2017 | 129.22M |
| June 30, 2017 | 137.39M |
| March 31, 2017 | 144.52M |
| December 31, 2016 | 153.41M |
| September 30, 2016 | 166.29M |
| June 30, 2016 | 105.42M |
| March 31, 2016 | 76.21M |
| December 31, 2015 | 80.87M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
156.28M
Minimum
Sep 2023
308.85M
Maximum
Dec 2019
236.82M
Average
229.20M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| CRISPR Therapeutics AG | 2.340B |
| Addex Therapeutics Ltd | 15.24M |
| NLS Pharmaceutics Ltd | 1.194M |
| Molecular Partners AG | 189.80M |
| MoonLake Immunotherapeutics | 544.88M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 126.94M |
| Shareholders Equity (Quarterly) | 137.30M |
| Current Ratio | 1.796 |